Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Suda Vannaprasaht"'
Autor:
Pattarapong Makarawate, Narumol Chaosuwannakit, Suda Vannaprasaht, Dujdao Sahasthas, Seok Hwee Koo, Edmund Jon Deoon Lee, Wichittra Tassaneeyakul, Hector Barajas‐Martinez, Dan Hu, Kittisak Sawanyawisuth
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 6 (2017)
BackgroundBrugada syndrome (BrS) is an inherited primary arrhythmia disorder leading to sudden cardiac arrest. SCN5A, encoding the α‐subunit of the cardiac sodium channel (Nav1.5), is the most common pathogenic gene of BrS. An implantable cardiove
Externí odkaz:
https://doaj.org/article/80def1a533624d9988694a029290f977
Autor:
Pattarapong Makarawate, Narumol Chaosuwannakit, Suda Vannaprasaht, Wichittra Tassaneeyakul, Kittisak Sawanyawisuth
Publikováno v:
Journal of Arrhythmia, Vol 30, Iss 1, Pp 55-57 (2014)
Background: In Thailand and Southeast Asia, Brugada syndrome (BS) is a common inheritable cause of sudden cardiac arrest (SCA) due to polymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF). Currently, an implantable cardioverter d
Externí odkaz:
https://doaj.org/article/965f8ce622e548438bf8436670d464f4
Autor:
Sootthikarn Mungkhunthod, Santirhat Prommas, Apichaya Puangpetch, Pongsatorn Paholpak, Nontaya Nakkam, Chonlaphat Sukasem, Wichittra Tassaneeyakul, Suda Vannaprasaht
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05413a37b12afe10dfd20a7f04daf8e7
https://doi.org/10.2139/ssrn.4400892
https://doi.org/10.2139/ssrn.4400892
Publikováno v:
International Journal of Applied Pharmaceutics. :13-16
Objective: This study proposed to study the therapeutic dosage ranges and to determine the prevalence of and the risk factors for the adverse effectsof Thai tacrolimus-based therapy kidney transplant patients.Methods: The fifty-nine kidney transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a45d914b73320018b90b4ae967d98b38
https://doi.org/10.22159/ijap.2021.v13s1.y0053
https://doi.org/10.22159/ijap.2021.v13s1.y0053
Autor:
Kanyarat Khaeso, Patcharee Komvilaisak, Su-on Chainansamit, Nontaya Nakkam, Kunanya Suwannaying, Pitchayanan Kuwatjanakul, Keiko Hikino, Areerat Dornsena, Sirimas Kanjanawart, Napat Laoaroon, Suda Vannaprasaht, Takeshi Taketani, Wichittra Tassaneeyakul
Publikováno v:
Drug metabolism and pharmacokinetics. 43
6-Mercaptopurine (6-MP) is commonly used for treatment of acute lymphoblastic leukemia (ALL). The incidence of hematotoxicity caused by this drug is quite high in Asians even using a standard low dosage regimen. The present study was aimed to elucida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a19ab6d4e9ce059efc8992ca67f96c
https://pubmed.ncbi.nlm.nih.gov/35016134
https://pubmed.ncbi.nlm.nih.gov/35016134
Autor:
Suda Vannaprasaht, Kittrawee Kritmetapak, Cholatip Pongskul, Sirirat Anutrakulchai, Chulaporn Limwattananon
Publikováno v:
Br J Clin Pharmacol
Aims Although cytochromeP450(CYP)3A5 gene polymorphism affects personalized tacrolimus doses, there is no consensus as to whether CYP3A5 genotypes should be determined to adjust the doses. The aims were to compare the therapeutic ranges and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f91984438fffe61c2c4647cd5f2f49b
https://doi.org/10.1111/bcp.13980
https://doi.org/10.1111/bcp.13980
Autor:
Su-on Chainansamit, Suda Vannaprasaht, Piyathida Wongmast, Wichittra Tassaneeyakul, Sirimas Kanjanawart, Kanyarat Khaeso, Patcharee Komwilaisak, Nontaya Nakkam, Areerat Dornsena
Publikováno v:
J Pediatr Genet
Genetic polymorphisms of thiopurine S-methyltransferase (TPMT) and nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes have been proposed as key determinants of 6-mercaptopurine (6-MP)-induced myelosuppression in pediatric acute lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab9dc0f46ad826b2992c8ec4fe249bb
https://pubmed.ncbi.nlm.nih.gov/33552635
https://pubmed.ncbi.nlm.nih.gov/33552635
Autor:
Luangyot Thongthieang, Kritiya Butthongkomvong, Kosin Wirasorn, Duanggamon Muengsaen, Suda Vannaprasaht, Wichittra Tassaneeyakul, Parichart Pongthai
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO4-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dc98c535494216f6f8cb7e085beab2e
https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-10-11
https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-10-11
Autor:
Pattarapong Makarawate, Burabha Pussadhamma, Songsak Kiatchoosakun, Nitsupa Wattanachai, Chaiyasith Wongvipaporn, Suda Vannaprasaht, Sutthida Kaewmoongkun, Wichittra Tassaneeyakul
Publikováno v:
European Journal of Clinical Pharmacology
Purpose The aim of this study was to investigate the contributions of non-genetic and genetic factors on the variability of stable warfarin doses in Thai patients. Methods A total of 250 Thai patients with stable warfarin doses were enrolled in the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e253723293ce1434020bebb6e03f05
https://doi.org/10.1007/s00228-017-2265-8
https://doi.org/10.1007/s00228-017-2265-8
Publikováno v:
International journal of clinical pharmacy. 41(1)
Background Dosage quantities of tacrolimus (TAC) vary according to cytochrome P450 3A5 (CYP3A5) genotype. Genotyping is expected to optimize the response to TAC response and to minimize adverse effects. In Thailand, kidney transplantation is reimburs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd05856ff466afae990cbdaa57f19b8
https://pubmed.ncbi.nlm.nih.gov/30446894
https://pubmed.ncbi.nlm.nih.gov/30446894